Vir Biotechnology, Inc.
VIR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001706431
No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Vir Biotechnology, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 218
- +7 vs. Q3 2025
- Shares held
- 115.5M
- +8.55M (+8.0%) vs. Q3 2025
- Total value
- $696.5M
- +$85.8M (+14.1%) vs. Q3 2025
- New holders
- 33
- 64 more added
- Sold out
- 26
- 80 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 237 | $1.49B |
| Q1 2026 | 252 | $1.25B |
| Q4 2025 | 218 | $696.5M |
| Q3 2025 | 213 | $610.8M |
| Q2 2025 | 213 | $558.5M |
| Q1 2025 | 234 | $604.5M |
| Q4 2024 | 208 | $652.0M |
| Q3 2024 | 197 | $656.3M |
| Q2 2024 | 215 | $783.1M |
| Q1 2024 | 210 | $901.0M |
| Q4 2023 | 207 | $887.2M |
| Q3 2023 | 215 | $827.4M |
| Q2 2023 | 227 | $2.23B |
| Q1 2023 | 234 | $2.06B |
| Q4 2022 | 225 | $2.18B |
| Q3 2022 | 221 | $1.68B |
| Q2 2022 | 214 | $2.20B |
| Q1 2022 | 204 | $2.09B |
| Q4 2021 | 210 | $3.25B |
| Q3 2021 | 175 | $3.24B |
| Q2 2021 | 166 | $3.64B |
| Q1 2021 | 157 | $3.87B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Vir Biotechnology, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 930,908 | $5.61M | 0.00% | +529,925+132.2% | Added |
| Millennium Management LLC | 1,002,606 | $6.05M | 0.00% | −393,898−28.2% | Reduced |
| Candriam Luxembourg S.C.A. | 1,031,663 | $6.22M | 0.03% | +1,031,663 | New |
| Hudson Bay Capital Management LP | 1,325,000 | $7.99M | 0.05% | +413,118+45.3% | Added |
| Balyasny Asset Management LLC | 1,368,474 | $8.25M | 0.02% | +1,368,474 | New |
| Standard Life Aberdeen plc | 1,390,577 | $8.39M | 0.01% | −135,688−8.9% | Reduced |
| Goldman Sachs Group Inc | 1,568,904 | $9.46M | 0.00% | +47,102+3.1% | Added |
| Geode Capital Management, LLC | 2,328,207 | $14.0M | 0.00% | +81,985+3.6% | Added |
| OrbiMed Advisors LLC | 2,380,715 | $14.4M | 0.29% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 2,536,277 | $15.3M | 0.00% | −442,594−14.9% | Reduced |
| Morgan Stanley | 2,679,145 | $16.2M | 0.00% | −9,973−0.4% | Reduced |
| FMR LLC | 3,158,416 | $19.0M | 0.00% | −478,714−13.2% | Reduced |
| State Street Corp | 6,229,555 | $37.6M | 0.00% | +988,262+18.9% | Added |
| GSK plc | 8,550,954 | $51.6M | 6.45% | +8,550,954 | New |
| Vanguard Group Inc | 12,548,944 | $75.7M | 0.00% | −250,437−2.0% | Reduced |
| ARCH Venture Management, LLC | 12,916,663 | $77.9M | 11.95% | 00.0% | Unchanged |
| SB Investment Advisers (UK) Ltd | 13,116,977 | $79.1M | 0.79% | −3,567,064−21.4% | Reduced |
| BlackRock, Inc. | 16,330,103 | $98.5M | 0.00% | +362,447+2.3% | Added |
| Franklin Resources Inc | 0 | $0 | 0.00% | −205,994−100.0% | Sold out |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −160,000−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −150,312−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −143,068−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −96,717−100.0% | Sold out |
| Connective Capital Management, LLC | 0 | $0 | 0.00% | −75,470−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −70,477−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −66,109−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −43,175−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −36,451−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −33,200−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −19,000−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −17,086−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −14,620−100.0% | Sold out |
| CIBC Asset Management Inc | 0 | $0 | 0.00% | −10,006−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −10,010−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −6,825−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −1,940−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −468−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −456−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −373−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −139−100.0% | Sold out |
| Bell Investment Advisors, Inc | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −20−100.0% | Sold out |
| Salzhauer Michael | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Wolverine Trading, LLC | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |